Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · IEX Real-Time Price · USD
60.01
+0.66 (1.11%)
At close: May 1, 2024, 4:00 PM
60.30
+0.29 (0.48%)
Pre-market: May 2, 2024, 7:15 AM EDT
Exact Sciences Revenue
In the year 2023, Exact Sciences had annual revenue of $2.50B with 19.93% growth. Revenue in the quarter ending December 31, 2023 was $646.89M with 16.98% year-over-year growth.
Revenue (ttm)
$2.50B
Revenue Growth
+19.93%
P/S Ratio
4.41
Revenue / Employee
$378,752
Employees
6,600
Market Cap
11.03B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.50B | 415.49M | 19.93% |
Dec 31, 2022 | 2.08B | 317.19M | 17.95% |
Dec 31, 2021 | 1.77B | 275.70M | 18.49% |
Dec 31, 2020 | 1.49B | 615.10M | 70.19% |
Dec 31, 2019 | 876.29M | 421.83M | 92.82% |
Dec 31, 2018 | 454.46M | 188.47M | 70.86% |
Dec 31, 2017 | 265.99M | 166.61M | 167.66% |
Dec 31, 2016 | 99.38M | 59.94M | 151.99% |
Dec 31, 2015 | 39.44M | 37.64M | 2,093.38% |
Dec 31, 2014 | 1.80M | -2.35M | -56.61% |
Dec 31, 2013 | 4.14M | - | - |
Dec 31, 2012 | 4.14M | -19.00K | -0.46% |
Dec 31, 2011 | 4.16M | -1.18M | -22.10% |
Dec 31, 2010 | 5.34M | 586.00K | 12.32% |
Dec 31, 2009 | 4.76M | 5.63M | -648.79% |
Dec 31, 2008 | -867.00K | -2.67M | -148.22% |
Dec 31, 2007 | 1.80M | -2.95M | -62.15% |
Dec 31, 2006 | 4.75M | 500.00K | 11.76% |
Dec 31, 2005 | 4.25M | -685.00K | -13.88% |
Dec 31, 2004 | 4.94M | 2.03M | 70.11% |
Dec 31, 2003 | 2.90M | 2.00M | 223.41% |
Dec 31, 2002 | 897.00K | 846.00K | 1,658.82% |
Dec 31, 2001 | 51.00K | - | - |
Dec 31, 2000 | 0 | - | - |
Dec 31, 1999 | 0 | - | - |
Dec 31, 1998 | 0 | - | - |
Dec 31, 1997 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Tenet Healthcare | 20.91B |
Universal Health Services | 14.28B |
Solventum | 8.20B |
Smith & Nephew | 5.55B |
Catalent | 4.10B |
AptarGroup | 3.54B |
Teleflex | 2.97B |
Bruker | 2.96B |
EXAS News
- 1 day ago - Exact Sciences to Participate in May Investor Conference - Business Wire
- 17 days ago - Exact Sciences Names Aaron Bloomer as New Chief Financial Officer - Business Wire
- 21 days ago - Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes - Business Wire
- 23 days ago - Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024 - Business Wire
- 24 days ago - Exact Sciences Schedules First Quarter 2024 Earnings Call - Business Wire
- 4 weeks ago - Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment - Business Wire
- 5 weeks ago - Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer - Business Wire
- 5 weeks ago - Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner - Business Wire